Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
Clinical trial NCT05845723 · RECRUITING
Trial details
- NCT number
- NCT05845723
- Sponsor
- Peking Union Medical College Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.